Automated Cell Culture Systems Market Size (2024 - 2029)

Automated Cell Culture Systems Market Analysis

The Automated Cell Culture Systems Market size is estimated at USD 13.17 billion in 2024, and is expected to reach USD 19.64 billion by 2029, growing at a CAGR of 8.32% during the forecast period (2024-2029).

The automated cell culture systems market is a dynamic and rapidly evolving sector within the life sciences and biotechnology industries. This market is influenced by the rise in the demand for biopharmaceuticals, advancements in cell-based research, and the need for precise, reproducible, and high-throughput cell culture processes. These systems offer enhanced productivity, reduced contamination risks, and improved data management, making them indispensable in applications ranging from drug discovery and vaccine production to regenerative medicine and personalized therapies. With ongoing technological innovations and a growing emphasis on automation in research and production, the automated cell culture systems market is poised for continued growth and innovation.

Chronic conditions are on the rise, including cancer, diabetes, and autoimmune diseases. Automated cell culture systems play a crucial role in drug discovery and development to address these health challenges. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) data published in December 2022, approximately six in ten Americans have at least one chronic disease. This signifies a high prevalence of chronic diseases, which significantly impacts research and developments in biopharmaceuticals.

Apart from this, the report released by the World Health Organization (WHO) in September 2023 points to the fact that around 41 million people die each year due to a chronic illness, which includes cardiovascular disorders followed by cancer and other chronic illnesses. This number projects a high number of treatment cases around the world, which would eventually impact the market’s growth. Biopharmaceuticals are required due to the rising burden of chronic diseases in the world, which is driving this market's expansion.

Apart from this, ongoing advancements in cell-based research, including regenerative medicine, tissue engineering, and personalized medicine, require precise and controlled cell culture conditions, which automated systems can provide. Factors such as collaboration for introducing new technologies in regenerative medicines and launching new systems further propel the market's growth.

For instance, Sony Group Corporation launched a new Cell Isolation System, CGX10, in December 2022. This device facilitates rapid cell sorting and can be used in studies to create cell-based products for industries like cell therapy and regenerative medicine. Also, for instance, in March 2023, Canon Inc. acquired assets of Kyoto Seisakusho Co. Ltd, which included the technology for mass production of cells for use in regenerative medicines and other clinical applications. These instances point out the growth of the market due to the advancements in this field of interest.

Therefore, the market is expected to grow during the forecast period due to factors such as the increased demand for biopharmaceuticals, rising incidence of chronic diseases, and advancements in cell-based research. However, factors such as high investment costs for the automated cell culture systems and regulatory compliance challenges act as restraining parameters for the market's growth.

Automated Cell Culture Systems Industry Segmentation

Automated cell culture systems are specialized laboratory equipment and setups designed to automate the process of growing and maintaining cell cultures.

The automated cell culture systems market is segmented into products, cell culture types, applications, end users, and geography. The market is segmented by product into cell culture process automation instruments, automated bioreactors, automated cell culture media exchange systems, automated culture media analyzers, automated cell counters, and others. By cell culture types, the market is segmented into finite cell line cultures and infinite cell line cultures. The market is segmented by application into cancer research, drug development, stem cell research, regenerative medicine, and cell therapy. By end user, the market is segmented into pharmaceutical companies, biotechnology companies, CDMOs/CMOs, research organizations, academic institutes, and hospitals providing cell therapy/regenerative medicine. The market is segmented by geography into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report offers the value (USD) for the above segments.